Danish biotech to buy struggling American oncology company

Danish drugmaker Pharmacosmos has agreed to acquire American pharmaceutical company G1 Therapeutics in a deal that amounts to 405 million dollars.

SGS Fimko Ltd.

JMP Statistical Discovery

Leo Pharma omorganiserar och kapar 200 tjänster

Danska Leo Pharma drar ned på personal i sin globala verksamhet. Runt 200 tjänster försvinner medan 50 flyttas till Polen.

QPS Netherlands B.V

Advancing 3D Culture Imaging: Insights from Academia, Biotech, and Pharma

Webinar | March 13, 2024, 12 PM EST.

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

Optimize Your Visibility

ZEISS presents our newest VersaXRM® 730 3D X-ray microscope.

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

ProPharma

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Medeon AB

TECHNIA AB

Samarbete med rekryteringspartner har många vinster för Life Science-företag

Acquisition Manager, Anna Arnebrant, delar sin syn på saken.

Zelmic

Meribel Pharma Solna

Metabolon

RegFile AB

Are you ready for EMC 2024?

Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.

Sahlgrenska Science Park

A modular system for precise and automated cell dispensing

How the benefits of laboratory automation can be combined with gentle cell handling.

Kompauto Nordic AB

Merck Life Science A/S

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.